“…Mouse TIS21 [11] and rat PC3 [12] are homologs of human B-cell translocation gene-2 (BTG2). The data accumulated during the past two decades with both cells and animal models implicate Btg2/TIS21/PC3 (Btg2) in a variety of biological processes such as mediation of stage specific expansion of developing thymocytes [13], regulation of the hematopoietic progenitor cell expansion in response to estradiol [14], cell cycle arrest at G2/M [15] and G1/S phases [16,17], enhancement of cancer cell death via interaction with Pin-1 in response to growth factor stimulation [18] or via accumulation of hydrogen peroxide after doxorubicin treatment [19], and regulation of neuronal differentiation [20,21]. Moreover, Btg2 is involved in the differentiation of myelocytic leukemia cells and CD34 + hematopoietic precursor cells [22,23], DNA repair [24,25], inhibition of cancer cell migration [26], as a transcriptional co-regulator in different model systems, and in the antioxidant defenses through the antioxidant transcription factor NFE2L2 [22,27].…”